The last decade has seen several attempts to develop non-isotopic immunoassays with a view to replacing radioimmunoassay methods which have many well documented disadvantages.
Several approaches have been made to the use of metal ions as labels in immunoassay: CaislJ used derivatives of sandwich compounds such as ferrocene to label steroids and other molecules, detection of the labelled species being carried out by atomic-absorption spectrometry. These labels were relatively insensitive in immunoassays, no doubt partly because the metals used (Fe, Mn, etc.) occur at high concentrations in biological samples. Cais subsequently synthesised metallohaptens by the mercuration of steroid estrogens,3 where the metal atoms were introduced directly into the molecule of the antigen, and by the formation of cymatrene complexes containing manganese. 4 Leuvering et al. 5 have studied the use of colloidal coating with atomic-absorption spectrometric determination.
In this paper we report the potential use of lanthanide ions as labels in immunoassay. In principle, lanthanide ion complexes should form useful labels in immunoassay as they are highly fluorescent and the concentration of lanthanide ions in biological samples is extremely low. In particular, a study has been made of the potential of the complex between terbium and transferrin as a label in the immunoassay of gentamicin.
Human serum transferrin has the function in the body of binding and transporting iron in the plasma in the form of Fe3+. Transferrin binds two iron(II1) ions per molecule in specific sites on the polypeptide chain, but in the absence of iron these sites may be occupied by lanthanide ions to form highly fluorescent complexes.
Gentamicin is an aminoglycosidic antibiotic used in the treatment of severe Gram-negative bacteria. Its optimum therapeutic concentration in human serum is 4-12 mg 1-1 (9-20 pmol I -l ) , maintained by intramuscular injection: 0.8 mg per kilogram body mass every 8 h. It is extremely effective but has a low therapeutic ratio and therefore its level must be monitored by a simple, rapid and reliable method.
Experimental Apparatus
All fluorescence spectra were measured on a Perkin-Elmer Model LS-5 luminescence spectrometer fitted with an R928 photomultiplier. Data were recorded using a Perkin-Elmer Model 3600 data station using PECLS I1 applications software, which permitted the calculation of corrected spectra and phosphorescence lifetimes.
Reagents
Terbium chloride and glycine were obtained from Aldrich Chemical Co. and iron-free transferrin, gentamicin sulphate and l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride from Sigma London Chemical Co.
All radioimmunoassays were carried out using a radioimmunoassay kit supplied by RIA (UK) Ltd.
Antibodies used in the antibody binding experiments were supplied by Sigma Chemical Co. Ltd.
Fluorescence of Terbium and the Terbium -Transferrin Complex
Fluorescence spectra of terbium chloride in aqueous solution and a terbium -transferrin complex in Tris -hydrochloric acidhydrogen carbonate buffer6 were recorded.
The limits of detection of the complex and its fluorescence lifetime (the time for the fluorescence of a sample to decay to the background level) were also determined.
The complex for the above experiments was prepared by the addition of aqueous terbium chloride to iron-free transferrin in Tris -hydrochloric acid -hydrogen carbonate buffer in the molar ratio 2 : 1.
Linkage of Gentamicin to Transferrin
The linkage of gentamicin to transferrin was achieved using a carbodiimide reagent. In this procedure a free acid group on the transferrin molecule is linked to a free amino group on the gentamicin. Experiments were carried out using 1-ethyl-3-(3-dimethylaminopropy1)carbodiimide hydrochloride in aqueous solution.
Iron-free transferrin (30 mg), gentamicin (60 mg) and the carbodiimide (400 mg) were incubated at room temperature in distilled water (2.5 ml) for varying lengths of time before separation of the protein fraction on a Sephadex G-25 column by elution with Tris -hydrochloric acid -hydrogen carbonate buffer (pH 8.5). Verification of gentamicin binding was carried out using 125I-labelled gentamicin.
The carbodiimide procedure was repeated using various glycine to gentamicin ratios for the gentamicin in the original experiment, the reaction time being 5 min in each instance.
The reaction products were subsequently analysed for their gentamicin content by radioimmunoassay and their fluorescence was measured after terbium binding. The effect on the fluorescence of the complex in various concentrations of antiserum to gentarnicin (raised in rabbit) was investigated using the double antibody technique with anti-rabbit IgG. Fluorescence measurements were taken following incubation, precipitation and centrifugation. Fig. 1 shows an enhancement of the fluorescence intensity of terbium of the order of 105 when the complex is excited at 295 nm. This fluorescence enhancement is due to an intramole cular energy transfer process within the complex. This is demonstrated by the fact that the complex excitation is in the region of the ligand absorbing region whereas the emission is typical of the "line" emission of the terbium ion. The limit of detection of the complex was shown to be 10-7 M with respect to transferrin, a result which suggests that the complex has a suitable fluorescence intensity for use as a label in the analysis of drugs by immunoassay.
Results and Discussion

Fluorescence of Terbium and the Terbium · Transferrin Complex
The complex had a lifetime of 1.25 ms. Subsequent delayed fluorescence experiments (Fig. 2) showed that interference due to scattered light from blood serum could be reduced to zero with a delay gate of 0.05 ms. The subsequent decrease in fluorescence intensity of the complex was l�ss than 5%. The following instrumental conditions were thus chosen: excita tion slit, 5.0 nm; emission slit, 5.0 nm; excitation wavelength, 295 nm; delay time, 0.05 ms; gate time, 5.0 ms; and fixed-scale mode. 
Linkage of Gentamicin to Transferrin
The experiments carried out using 12s1.1abelled gentamicin showed that with reaction times from 5 min to 1 h substantial gentamicin binding was occurring. Table 1 shows the amount of gentamicin bound per millilitre of solution for various reaction mixtures as analysed by standard radioimmunoassay for gentamicin. It can be seen that gentamicin -glycine bound complexes with glycine to gentamicin ratios of less than 15 : 5 have too high a gentamicin content for use in a competitive binding assay for the therapeutic blood concentration range of gentamicin (4--12 µg ml-1).
Analysis of the Gentamicin Content of Complexes with Substituted Glycine
Fluorescence measurements on the complexes modified by glycine and gentamicin showed a decrease in fluorescence intensity of less than 5% compared with the original terbiumtransferrin complex.
Stability of the Gentamicin -Glycine Bound Complex
It can be seen from Table 2 that a complex containing a glycine to gentamicin ratio of 9 : 1 is stable in buffer and buffer containing 1 : 100 human serum over a period of at least 7 d.
Absorbance measurements at 295 nm showed that the decrease in fluorescence intensity in 1 : 100 serum was due to the increased absorbance of the solution at that wavelength.
Titration of the Glycine -Gentamicin Complex against Anti-gentamicin
Titration of the complex against anti-gentamicin (Fig. 3) shows good antibody recognition of the complex, the curve shape being typical of such a dilution analysis. 
Conclusion
The results suggest that a glycine -gentamicin bound terbiumtransferrin complex has potential as a non-isotopic immunoas say label. However, it is felt that careful consideration should be given to the final format of the immunoassay, owing to possible effects of the macromolecular label. At present the most suitable separation methods are being established.
Although the terbium -transferrin complex shows potential as an alternative label in immunoassay, it has the disadvantage of sensitivity suitable only for the detection of drugs and not hormones. One means of increasing the sensitivity is to increase the fluorescence intensity. Further study of the intramolecular energy transfer process 7 -8 such as are involved in the terbium -transferrin complex might prove useful in this respect. The bifunctional reagents that would be suitable are of the type described by Meares and co-workers, 9 11J which have "EDT A" groups and groups suitable for binding to amino acids at opposite extremities of the molecule. Another alternative is the use of bifunctional reagents where the chelating agent is "iminodiacetic acid . "11 12
